Global WholeHealth Partners (GWHP) Stock Price, News & Analysis

Company Overview

Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic (IVD) test kits in the United States. The company offers approximately 125 diagnostic tests kits for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, yellow fever, and other epidemic and vector-borne diseases. The company was incorporated in 2013 and is based in Newport Beach, California.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $10,000.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GWHP Stock Analysis - Frequently Asked Questions

When did Global WholeHealth Partners' stock split?

Shares of Global WholeHealth Partners split on the morning of Wednesday, March 30th 2022. The 3-1 split was announced on Wednesday, March 30th 2022. The newly created shares were issued to shareholders after the closing bell on Wednesday, March 30th 2022. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

How do I buy shares of Global WholeHealth Partners?

Shares of GWHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Global WholeHealth Partners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Global WholeHealth Partners investors own include Data Storage (DTSTW), NET Power (NPWR), Pfizer (PFE), Verizon Communications (VZ), Walmart (WMT), Eli Lilly and Company (LLY) and Enterprise Products Partners (EPD).

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Diagnostic substances
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:GWHP
• CUSIP: N/A
• CIK: 1598308
• Web: gwhpcorp.com
• Phone: (714) 392-9752
• Fax: N/A
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $10,000.00
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 143,880,000
• Free Float: 129,065,000
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A